Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Method for Normal-independent calculation of TMB

Building reliable germline variant estimates appropriate for use in calculating burden

Long-Term Disease-Free Survival in High Grade Serous Ovarian Cancer...

Application of RNA-based immune signatures in predicting disease-free survival

Effect of tumor purity on somatic mutation detection using next-generation...

Application of experiment and in silico approaches

Sensitive Detection of MET Exon 14 Skipping by RT-PCR and Next Generation...

RT-PCR assay that detects MET exon 14 skipping independent of the causal mutation

Tumor Mutational Burden: Guidelines for derivation and robustness of...

Explore our Tumor Mutational Burden (TMB) calculation methodology

STAR-SEQR: Accurate fusion detection and support for neoantigen...

The update of STAR-SEQR to report extended annotation in support of neoantigen research

Effects of sequencing parameters and panel size on mutational burden...

Ramifications of varying cancer panel sizes and read depths on the calculation of TMB scores

The international MAQC Society launches to enhance reproducibility of...

Q2 Solutions participation in the next phase of the MAQC (SEQC-II) to help define rules for variant...

Copy number detection using Viterbi (Covit)

Presentation from Cancer Genomics Consortium, August 2017

Designing AML Panel for Clinical Testing

Presentation from PMWC - Duke University, May 2017

Accurate and Reproducible Detection of Fusions and Exon Skipping Events

Scientific Poster, co-authored with Asuragen, from AACR 2017

Translating Data into Insights with Bioinformatics